Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2024 08:01 ET | Source: Research and Markets

Global Narcolepsy Drugs Market Report 2024-2032: Therapeutic Types, Disease Types, End Users, Countries, and Company Analysis Featuring Jazz Pharmaceuticals, Ligand Pharmaceuticals, Novartis, and More

Dublin, July 30, 2024 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market Report by Therapeutic Type Disease Type End Users Countries and Company Analysis, 2024-2032" report has been added to ...
April 22, 2024 11:10 ET | Source: Research and Markets

Autistic Disorder Pipeline Insight Report 2024, Featuring Key Products Tasimelteon, Cariprazine, L1-79, JZP541, AB-2004, RO6953958 and SB-121

Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Autistic Disorder - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...
January 24, 2024 14:35 ET | Source: Research and Markets

Narcolepsy Drugs Industry Outlook to 2030: Emphasizing Growth in the Sodium Oxybate and Central Nervous System Stimulants Segments

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market (By Therapeutic Type, Disease Type, End User, Regional Analysis), Pipeline Analysis, Key Company Profiles and Recent...
November 07, 2023 06:48 ET | Source: Research and Markets

Sodium Oxybate Takes Center Stage in Narcolepsy Treatment: Key Player in $5.95 Billion Narcolepsy Drugs Industry by 2030

Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...
May 29, 2023 05:00 ET | Source: REPORTSINSIGHTS CONSULTING PVT LTD

Panic Disorder Market Towards US$ 12,621.61 Mn By 2030, A Comprehensive Analysis By Reports Insights

New York, May 29, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Reports Insights, the panic disorder market is poised for strong expansion and is expected to reach USD 12,621.61 Million...
March 10, 2023 05:53 ET | Source: Research and Markets

Global Acute Migraine Drugs Market Report 2023: A $14.06 Billion Market by 2028 Featuring Key Players - Eli Lilly and Co, GSK, Bayer, J&J, Teva, AbbVie, Novartis, Merck, Pfizer, & Boehringer Ingelheim

Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By...
February 16, 2023 11:33 ET | Source: Research and Markets

The Worldwide Narcolepsy Therapeutics Industry is Projected to Reach $3.6 Billion by 2030 at a CAGR of 7.3%

Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Narcolepsy Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Narcolepsy...
December 29, 2022 07:08 ET | Source: Research and Markets

Autism Spectrum Disorder Treatment Global Market Report 2022: Sector to Grow by 6.47% Annually Through 2033

Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Autism Spectrum Disorder Treatment Market by Treatment, Application, Distribution Channel, and by Region - Global Forecast to 2022-2033" report has...
November 10, 2022 07:08 ET | Source: Research and Markets

Global Narcolepsy Therapeutics Market Report to 2028: Growing Healthcare Expenditures and Increasing Prevalence of Neurological Conditions are Driving Factors

Dublin, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Product (Sodium Oxybate, Selective Serotonin...
February 28, 2022 05:28 ET | Source: Research and Markets

Global Narcolepsy Drugs Market Report 2022 - Sodium Oxybate Dominates, Owing to Its Dual-Pronged Approach in Treating Daytime Extreme Sleepless and Cataplexy

Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Narcolepsy Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been...

Next Page keyboard_arrow_right